Ovid Therapeutics (OVID) EBIT (QoQ) (2016 - 2026)
Ovid Therapeutics (OVID) EBIT (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.17% |
| Dec 31, 2025 | 1.84% |
| Sep 30, 2025 | -146.86% |
| Jun 30, 2025 | 59.58% |
| Mar 31, 2025 | -17.05% |
| Dec 31, 2024 | 18.93% |
| Sep 30, 2024 | 35.54% |
| Jun 30, 2024 | -17.80% |
| Mar 31, 2024 | 4.24% |
| Dec 31, 2023 | -51.20% |
| Sep 30, 2023 | 15.12% |
| Jun 30, 2023 | 4.83% |
| Mar 31, 2023 | -22.34% |
| Dec 31, 2022 | 4.93% |
| Sep 30, 2022 | 10.49% |
| Jun 30, 2022 | 12.07% |
| Mar 31, 2022 | 38.27% |
| Dec 31, 2021 | -125.60% |
| Sep 30, 2021 | 18.38% |
| Jun 30, 2021 | -108.11% |